Pulmonary Carcinoid Surface Receptor Modulation Using Histone Deacetylase Inhibitors.

Cancers (Basel) · 2019 · PMC6627607 · PMID 31163616

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

A dose of 1 μM AB3 (mean ± SEM, 2.10 ± 0.02, p = 0.822) also showed a trend toward increased SSTR2 expression, but this increase was not found to be significant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.